Int J Stomatol

Int J Stomatol ›› 2026, Vol. 53 ›› Issue (4): 476-486.doi: 10.7518/gjkq.2026226

• Interpretation of Consensus • Previous Articles     Next Articles

Interpretation of the Academy of Osseointegration/American Academy of Periodontology consensus on the prevention and management of peri-implant diseases and conditions

Hanping Xia1(),Juan Liu1,Wenlan Xiao2,Yujie Yao1,Xin Tong2,Fuhua Yan1,Bin Chen1()   

  1. 1.Dept. of Periodontology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomato-logy, Nanjing University, Nanjing 210008, China
    2.Dept. of Implantology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210008, China
  • Received:2025-07-03 Revised:2025-09-11 Online:2026-07-01 Published:2026-06-25
  • Contact: Bin Chen E-mail:522024350242@smail.nju.edu.cn;binchen@nju.edu.cn
  • Supported by:
    Ningxia Hui Autonomous Region Key R&D Program in Social Development(2025BEG02007);National Key Research and Development Program of China(2023YFC2506300);Nanjing Health Technology Development Project(ZKX22054)

RichHTML

1

PDF (PC)

10

Abstract:

The article “Academy of Osseointegration/American Academy of Periodontology consensus on the prevention and management of peri-implant diseases and conditions: summary report” was published in June 2025. This consensus, supported by eight systematic reviews, focused on the prevention and management of peri-implant diseases and conditions. It placed a particular focus on the risk factors and therapeutic strategies for peri-implant mucositis, peri-implantitis, peri-implant soft tissue deficiency, and peri-implant marginal bone loss. It analyzed the effects of systemic diseases; behavioral, patient-related, and surgical factors; implant site conditions; and prosthetic design on the occurrence of peri-implant diseases and conditions and stratified their risk levels. Clinical guidelines for the prevention and management of different peri-implant diseases and conditionswere proposed on the basis of the above risk factors. This article aims to provide a critical interpretation of the consensus in the context of China’s clinical practice, synthesizing evidence-based recommendations and expert opinions to enhance clinicians’ understanding of peri-implant disease and condition management, thereby improving long-term implant survival rates.

Key words: peri-implant diseases, peri-implant mucositis, peri-implant soft tissue deficiency, peri-implantitis, supportive peri-implant therapy

CLC Number: 

  • R781.4

TrendMD: 

Tab 1

Risk factor grading of peri-implant diseases and conditions"

种植体周病和状况高风险中风险其他
种植体周黏膜炎吸烟或吸烟史*；牙周炎病史；未控制的牙周炎*肥胖*；肥胖和/或代谢综合征*；薄软组织表型
种植体周炎未控制/控制不佳的糖尿病；吸烟或吸烟史；牙周炎病史；未控制的牙周炎抑郁症/服用抗抑郁药物；代谢综合征；种植体近远中向间距<3 mm；种植体平台冠根向距邻牙CEJ>6 mm；植入部位骨宽度不足；基台/界面与牙槽骨距离过近软组织表型是种植体周炎的重要影响因素
种植体周MBL平台匹配基台；穿龈高度<2 mm；穿龈轮廓角度>30°；粘接剂残留*种植体支持式联冠修复凸形基台穿龈轮廓增加骨水平种植体发生MBL的风险
PSTD凸形基台穿龈轮廓；颊侧骨开裂*；角化龈宽度<2 mm；颊侧黏膜厚度不足；邻面MBL*；植入位置偏颊侧即刻植入*；植入超过5年*；种植体轴向偏颊

Fig 1

Treatment protocol for peri-implant mucositis"

Fig 2

Treatment protocol for peri-implantitis"

[1] Kim WJ, Cho YD, Ku Y, et al. The worldwide pa-tent landscape of dental implant technology[J]. Biomater Res, 2022, 26(1): 59.
[2] Herrera D, Sanz M, Kebschull M, et al. Treatment of stage Ⅳ periodontitis: the EFP S3 level clinical practice guideline[J]. J Clin Periodontol, 2022, 49(): 4-71.
[3] West N, Chapple I, Culshaw S, et al. BSP Implementation of prevention and treatment of peri-implant diseases—the EFP S3 level clinical practice guideline[J]. J Dent, 2024, 149: 104980.
[4] Wang HL, Avila-Ortiz G, Monje A, et al. AO/AAP consensus on prevention and management of peri-implant diseases and conditions: summary report[J]. J Periodontol, 2025, 96(6): 519-541.
[5] Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology[J]. J Clin Periodontol, 2015, 42(): S158-S171.
[6] Lee CT, Huang YW, Zhu L, et al. Prevalences of peri-implantitis and peri-implant mucositis: systema-tic review and meta-analysis[J]. J Dent, 2017, 62: 1-12.
[7] Romandini M, Lima C, Pedrinaci I, et al. Prevalence and risk/protective indicators of peri-implant disea-ses: a university-representative cross-sectional study[J]. Clin Oral Implants Res, 2021, 32(1): 112-122.
[8] Apaza-Bedoya K, Galarraga-Vinueza ME, Correa BB, et al. Prevalence, risk indicators, and clinical characteristics of peri-implant mucositis and peri-implantitis for an internal conical connection implant system: a multicenter cross-sectional study[J]. J Periodontol, 2024, 95(6): 582-593.
[9] Obreja K, Ramanauskaite A, Begic A, et al. The prevalence of peri-implant diseases around subcres-tally placed implants: a cross-sectional study[J]. Clin Oral Implants Res, 2021, 32(6): 702-710.
[10] Shi JY, Jie N, Zhuang LF, et al. Peri-implant conditions and marginal bone loss around cemented and screw-retained single implant crowns in posterior regions: a retrospective cohort study with up to 4 years follow-up[J]. PLoS One, 2018, 13(2): e0191717.
[11] Tavelli L, Barootchi S. Prevalence, incidence, risk, and protective factors for soft tissue dehiscences at implant sites in the absence of disease: an AO/AAP systematic review and meta-regression analysis[J]. J Periodontol, 2025, 96(6): 562-586.
[12] Gamborena I, Avila-Ortiz G. Peri-implant marginal mucosa defects: classification and clinical management[J]. J Periodontol, 2021, 92(7): 947-957.
[13] Romandini M, Pedrinaci I, Lima C, et al. Prevalence and risk/protective indicators of buccal soft tissue dehiscence around dental implants[J]. J Clin Periodontol, 2021, 48(3): 455-463.
[14] Renvert S, Polyzois I. Treatment of pathologic peri-implant pockets[J]. Periodontol 2000, 2018, 76(1): 180-190.
[15] Heitz-Mayfield LJ, Mombelli A. The therapy of peri-implantitis: a systematic review[J]. Int J Oral Maxillofac Implants, 2014, 29(): 325-345.
[16] Sanz M, Solonko M, Luengo F. Key factors in prevention of peri-implant diseases[J]. Compend Contin Educ Dent, 2017, 38(8 ): 6-13.
[17] Carra MC, Blanc-Sylvestre N, Courtet A, et al. Primordial and primary prevention of peri-implant di-seases: a systematic review and meta-analysis[J]. J Clin Periodontol, 2023, 50(): 77-112.
[18] Lee JCY, Mattheos N, Nixon KC, et al. Residual periodontal pockets are a risk indicator for peri-implantitis in patients treated for periodontitis[J]. Clin Oral Implants Res, 2012, 23(3): 325-333.
[19] Roccuzzo A, Imber JC, Marruganti C, et al. Clinical outcomes of dental implants in patients with and without history of periodontitis: a 20-year prospective study[J]. J Clin Periodontol, 2022, 49(12): 1346-1356.
[20] Alhakeem M, Kanounisabet N, Nowzari H, et al. Risk indicators of long-term outcome of implant therapy in patients with a history of severe periodontitis or no history of periodontitis: a retrospective cohort study[J]. Int J Dent Hyg, 2023, 21(1): 227-237.
[21] Renvert S, Polyzois I. Risk indicators for peri-implant mucositis: a systematic literature review[J]. J Clin Periodontol, 2015, 42(): S172-S186.
[22] Renvert S, Quirynen M. Risk indicators for peri-implantitis. A narrative review[J]. Clin Oral Implants Res, 2015, 26(): 15-44.
[23] Costa FO, Lages EJP, Cortelli SC, et al. Association between cumulative smoking exposure, span since smoking cessation, and peri-implantitis: a cross-sectional study[J]. Clin Oral Investig, 2022, 26(7): 4835-4846.
[24] Galindo-Moreno P, Fauri M, Avila-Ortiz G, et al. Influence of alcohol and tobacco habits on peri-implant marginal bone loss: a prospective study[J]. Clin Oral Implants Res, 2005, 16(5): 579-586.
[25] Carr BR, Boggess WJ, Coburn JF, et al. Does alcohol consumption protect against late dental implant failures[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2021, 131(6): 631-637.
[26] Monje A, Aranda L, Diaz KT, et al. Impact of maintenance therapy for the prevention of peri-implant diseases: a systematic review and meta-analysis[J]. J Dent Res, 2016, 95(4): 372-379.
[27] Chan D, Pelekos G, Ho D, et al. The depth of the implant mucosal tunnel modifies the development and resolution of experimental peri-implant mucositis: a case-control study[J]. J Clin Periodontol, 2019, 46(2): 248-255.
[28] Monje A, Kan JY, Borgnakke W. Impact of local predisposing/precipitating factors and systemic dri-vers on peri-implant diseases[J]. Clin Implant Dent Relat Res, 2023, 25(4): 640-660.
[29] Galindo-Moreno P, León-Cano A, Ortega-Oller I, et al. Prosthetic abutment height is a key factor in peri-implant marginal bone loss[J]. J Dent Res, 2014, 93(7 ): 80S-85S.
[30] Blanco J, Pico A, Caneiro L, et al. Effect of abutment height on interproximal implant bone level in the early healing: a randomized clinical trial[J]. Clin Oral Implants Res, 2018, 29(1): 108-117.
[31] Katafuchi M, Weinstein BF, Leroux BG, et al. Restoration contour is a risk indicator for peri-implantitis: a cross-sectional radiographic analysis[J]. J Clin Periodontol, 2018, 45(2): 225-232.
[32] Strauss FJ, Siegenthaler M, Hämmerle CHF, et al. Restorative angle of zirconia restorations cemented on non-original titanium bases influences the initial marginal bone loss: 5-year results of a prospective cohort study[J]. Clin Oral Implants Res, 2022, 33(7): 745-756.
[33] Mattheos N, Janda M, Acharya A, et al. Impact of design elements of the implant supracrestal complex (ISC) on the risk of peri-implant mucositis and peri-implantitis: a critical review[J]. Clin Oral Implants Res, 2021, 32(): 181-202.
[34] Pjetursson BE, Thoma D, Jung R, et al. A systema-tic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years[J]. Clin Oral Implants Res, 2012, 23(): 22-38.
[35] Zucchelli G, Tavelli L, Stefanini M, et al. Classification of facial peri-implant soft tissue dehiscence/deficiencies at single implant sites in the esthetic zone[J]. J Periodontol, 2019, 90(10): 1116-1124.
[36] Kumar PS, Kan J, Galarraga-Vinueza ME, et al. Risk for peri-implant diseases and defects: report of workgroup 1 of the joint AO/AAP consensus confe-rence on prevention and management of peri-implant diseases[J]. Clin Adv Periodontics, 2025, 15(2): 93-102.
[37] Fiorellini JP, Mojaver S, Sarmiento H, et al. Clinical translation of the 2024 AO/AAP consensus on prevention and management of peri-implant diseases and conditions[J]. Int J Periodontics Restorative Dent, 2025, 45(4): 1-23.
[38] Galarraga-Vinueza ME, Pagni S, Finkelman M, et al. Prevalence, incidence, systemic, behavioral, and patient-related risk factors and indicators for peri-implant diseases: an AO/AAP systematic review and meta-analysis[J]. J Periodontol, 2025, 96(6): 587-633.
[39] Monje A, Barootchi S, Rosen PS, et al. Surgical- and implant-related factors and onset/progression of peri-implant diseases: an AO/AAP systematic review[J]. J Periodontol, 2025, 96(6): 542-561.
[40] Lin GH, Lee E, Barootchi S, et al. The influence of prosthetic designs on peri-implant bone loss: an AO/AAP systematic review and meta-analysis[J]. J Pe-riodontol, 2025, 96(6): 634-651.
[41] Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Di-seases and Conditions[J]. J Clin Periodontol, 2018, 45(): S286-S291.
[42] Tavelli L, Barootchi S, Majzoub J, et al. Volumetric changes at implant sites: a systematic appraisal of traditional methods and optical scanning-based digital technologies[J]. J Clin Periodontol, 2021, 48(2): 315-334.
[43] Tavelli L, Barootchi S, Majzoub J, et al. Prevalence and risk indicators of midfacial peri-implant soft tissue dehiscence at single site in the esthetic zone: a cross-sectional clinical and ultrasonographic study[J]. J Periodontol, 2022, 93(6): 857-866.
[44] Sanz-Martín I, Regidor E, Navarro J, et al. Factors associated with the presence of peri-implant buccal soft tissue dehiscences: a case-control study[J]. J Periodontol, 2020, 91(8): 1003-1010.
[45] Lin GH, Chambrone L, Rajendran Y, et al. Treatment of peri-implant mucositis: an AAP/AO syste-matic review and meta-analysis[J]. Int J Oral Maxillofac Implants, 2025(4): 49-72.
[46] Ravidà A, Dias DR, Lemke R, et al. Efficacy of decontamination methods for biofilm removal from dental implant surfaces and reosseointegration: an AAP/AO systematic review on peri-implant disea-ses and conditions[J]. Int J Oral Maxillofac Implants, 2025(4): 91-160.
[47] Saleh MHA, Misch C, Alrmali A, et al. Efficacy of nonreconstructive surgical treatment of peri-implantitis: an AAP/AO systematic review and meta-analysis of access flap versus osseous surgery procedures[J]. Int J Oral Maxillofac Implants, 2025(4): 73-90.
[48] Barootchi S, Monje A, Sabri H, et al. Surgical reconstructive therapy for the management of peri-implantitis: an AAP/AO systematic review and network meta-analysis[J]. Int J Oral Maxillofac Implants, 2025(4): 1-48.
[49] Figuero E, Graziani F, Sanz I, et al. Management of peri-implant mucositis and peri-implantitis[J]. Perio-dontol 2000, 2014, 66(1): 255-273.
[50] Jepsen S, Berglundh T, Genco R, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis[J]. J Clin Periodontol, 2015, 42(): S152-S157.
[51] Rakic M, Tatic Z, Radovanovic S, et al. Resolution of peri-implant mucositis following standard treatment: a prospective split-mouth study[J]. J Perio-dontol, 2024, 95(9): 842-852.
[52] Iorio-Siciliano V, Blasi A, Isola G, et al. Resolution of peri-implant mucositis at tissue- and bone-level implants: a 6-month prospective controlled clinical trial[J]. Clin Oral Implants Res, 2023, 34(5): 450- 462.
[53] Herrera D, Berglundh T, Schwarz F, et al. Prevention and treatment of peri-implant diseases—the EFP S3 level clinical practice guideline[J]. J Clin Periodontol, 2023, 50(): 4-76.
[54] Roccuzzo M, Layton DM, Roccuzzo A, et al. Clinical outcomes of peri-implantitis treatment and supportive care: a systematic review[J]. Clin Oral Implants Res, 2018, 29(): 331-350.
[55] Butera A, Maiorani C, Gallo S, et al. Evaluation of adjuvant systems in non-surgical peri-implant treatment: a literature review[J]. Healthcare, 2022, 10(5): 886.
[56] Blanco C, Pico A, Dopico J, et al. Adjunctive benefits of systemic metronidazole on non-surgical treatment of peri-implantitis. A randomized placebo-controlled clinical trial[J]. J Clin Periodontol, 2022, 49(1): 15-27.
[57] Ramanauskaite A, Schwarz F. Current concepts for the treatment of peri-implant disease[J]. Int J Pros-thodont, 2024, 37(2): 124-134.
[58] Schwarz F, John G, Mainusch S, et al. Combined surgical therapy of peri-implantitis evaluating two methods of surface debridement and decontamination. A two-year clinical follow up report[J]. J Clin Periodontol, 2012, 39(8): 789-797.
[59] Monje A, Pons R, Peña P. Electrolytic surface decontamination in the reconstructive therapy of peri-implantitis: single-center outcomes[J]. Int J Perio-dontics Restorative Dent, 2025, 45(2): 185-198.
[60] Carcuac O, Derks J, Abrahamsson I, et al. Surgical treatment of peri-implantitis: 3-year results from a randomized controlled clinical trial[J]. J Clin Perio-dontol, 2017, 44(12): 1294-1303.
[61] Karlsson K, Derks J, Håkansson J, et al. Interventions for peri-implantitis and their effects on further bone loss: a retrospective analysis of a registry-based cohort[J]. J Clin Periodontol, 2019, 46(8): 872-879.
[62] Donos N, Calciolari E, Ghuman M, et al. The efficacy of bone reconstructive therapies in the management of peri-implantitis. A systematic review and meta-analysis[J]. J Clin Periodontol, 2023, 50(): 285-316.
[1] Weiyao Xia,Jing Wang,Yili Qu. Progress on etiology and treatment of retrograde peri-implantitis [J]. Int J Stomatol, 2026, 53(4): 496-502.
[2] Shuyu Zhu,Jing Zhou,Zhigang Xie. Balance between T-helper 17 cells and regulatory T cells in bone remodeling and their impact on oral and maxillofacial damage recovery [J]. Int J Stomatol, 2025, 52(4): 514-525.
[3] Jiamin Li,Yuchen Li,Zhangjie Ge,Lingzi Liao,Xin Guo,Xiaolong Guo,Ping Zhou. Advancements in the study of antimicrobial peptides in the coating of oral titanium implants [J]. Int J Stomatol, 2024, 51(5): 572-584.
[4] Lu Qian,Xia Haibin,Wang Min.. Research progress on implantoplasty in the treatment of peri-implantitis [J]. Int J Stomatol, 2023, 50(2): 152-158.
[5] Man Yi, Huang Dingming. Combined treatment strategy of oral implantology and endodontic microsurgery for bone augmentation and en-dodontic diseases in aesthetic area (part 1): application basis and indications [J]. Int J Stomatol, 2022, 49(5): 497-505.
[6] Cao Zhengguo. Periodontal considerations in prosthetic dentistry [J]. Int J Stomatol, 2022, 49(1): 1-11.
[7] Zheng Guiting,Xu Yan,Wu Mingyue. Research progress and consensus of experts on the therapy of peri-implant diseases [J]. Int J Stomatol, 2020, 47(6): 725-731.
[8] Tong Zian,Si Misi. Advances in the decontamination of plaque on implant surface in vitro [J]. Int J Stomatol, 2020, 47(5): 589-594.
[9] Zhang Min,Wan Haoyuan. Research progress on drug and laser therapy for peri-implantitis [J]. Int J Stomatol, 2020, 47(4): 463-470.
[10] Wu Qiuyue,Li Zhibang. Research progress on the adjunctive drug therapy of peri-implantitis [J]. Int J Stomatol, 2020, 47(4): 471-477.
[11] Qing Wei,Huang Lijuan,Zheng Jiajun,Ren Jing,Li Chenglong,Tuo Qiang,Ren Xiaohua,Mu Yandong. Shift of microbial composition of peri-implant gingival crevicular fluid as revealed by 16S ribosomal DNA high-throughput sequencing [J]. Int J Stomatol, 2019, 46(5): 532-539.
[12] Huang Haixia, Lan Yuyan, Zhang Hao, Pan Lanlan, Guo Ling, Liu Min. Changes on periodontal index and inflammatory factor levels in gingival crevicular fluid after implant restoration in patients with chronic periodontitis [J]. Inter J Stomatol, 2018, 45(4): 396-402.
[13] Meng Lingxian, Ban Yu.. Decontamination of implant surfaces for enhancing surgical treatment of peri-implantitis [J]. Inter J Stomatol, 2015, 42(4): 458-461.
[14] Sun Lei, Xia Rong.. Research progress on antibacterial titanium-based implant surface modification [J]. Inter J Stomatol, 2015, 42(4): 475-479.
[15] Li Yunyun, Fa Yonghong. Application progress on hyaluronic acid in the field of stomatology [J]. Inter J Stomatol, 2013, 40(3): 344-346.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[2] ZAN Lin, LIN Bao-shan, DENG Xiao, CHEN Song. Evaluation about the effects of non -extraction treatment for patients of differe[J]. Inter J Stomatol, 2009, 36(3): 276 -280 .
[3] . [J]. Foreign Med Sci: Stomatol, 2000, 27(03): .
[4] Chen Yi, Tao Renchuan, Lin Xuefang, Liu Zhenmin, Yong Xiangzhi, Li Runying.. The circadian rhythm expression of the human neutrophil peptide 1-3[J]. Inter J Stomatol, 2013, 40(4): 429 -431 .
[5] . [J]. Inter J Stomatol, 2008, 35(S1): .
[6] . [J]. Foreign Med Sci: Stomatol, 2000, 27(03): .
[7] Sun Yingying, Lin Chongtao.. Research progress on hypophosphatasia in the oral cavity[J]. Inter J Stomatol, 2011, 38(5): 581 -583 .
[8] . [J]. Foreign Med Sci: Stomatol, 2001, 28(01): .
[9] Lin Guofen, Chen Zhihong, Liu Li. . A preliminary clinical study of genotoxicity in oral mucosa cells exposed to Ni-Cr alloy[J]. Inter J Stomatol, 2013, 40(4): 444 -446 .
[10] Li Boxun, Liu Yi.. Combined surgical and orthodontic treatment on skeletal class Ⅰ bimaxillary protrusion: A case report[J]. Inter J Stomatol, 2013, 40(4): 462 -463 .